Nitzan Arad is an Area Lead for Drug Pricing with the Duke-Margolis Institute for Health Policy. Her work focuses on drug pricing and payment reforms, primarily in Medicare and Medicaid. Before joining Duke-Margolis, she was a Director of Public Policy at Teva Pharmaceuticals, where she led research and analysis on a variety of government pricing and reimbursement, intellectual property, trade policy and biosimilar issues, in the U.S. and international markets. She also interacted regularly with different industry associations and developed policy strategies to support company advocacy efforts on various topics.